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Available online 14 March 2008In mammalian embryos, PGCs (primordial germ cells) are speciﬁed from a pluripotent epiblast cell
population after implantation. In this study, we demonstrated an essential role for the germline-speciﬁc
transcription factor Oct3/4 in PGC speciﬁcation. We generated chimeric embryos with ZHBTc4 ES cells lacking
both alleles of the Oct3/4 gene (pou5f1). Pluripotency was maintained by an Oct3/4 transgene, and its
expression was suppressed by doxycycline (Dox). Transcription of the Oct3/4 transgene in the ES-derived
cells unexpectedly suffered constitutive suppression in chimeric embryos without Dox, and the ES-derived
cells contributed to PGC precursor-like cells, but failed to form PGCs. We then attempted to rescue Oct3/4
expression in the ES-derived cells in the chimeric embryos by introducing an additional Oct3/4 transgene.
The ES cell-derived cells indeed recovered Oct3/4 transcription in these chimeric embryos, and were
successfully speciﬁed to PGCs. We further conﬁrmed the requirement of Oct3/4 by using another derivative of
ZHBTc4 ES cells in which a Dex (dexamethasone)-dependent Oct3/4 transgene was introduced. In the
presence of Dox, Oct3/4 protein was absent in the nuclei of the ES-derived cells, which failed to form PGCs. In
contrast, the ES-derived cells could be speciﬁed to PGCs after activation of Oct3/4 function in the presence of
Dex.
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The protein Oct3/4 is encoded by pou5f1 and represents a
germline-speciﬁc transcription factor containing a POU-homeo box
domain (Okamoto et al., 1990; Rosner et al., 1990; Scholer et al., 1990).
Previous reports have indicated that Oct3/4 is essential for the
maintenance of pluripotent cells. Mouse embryos deﬁcient in pou5f1
cannot develop beyond the blastocyst stage at pre-implantation and
fail to establish a pluripotent inner cell mass (Nichols et al., 1998). In
addition, two-fold up- or down-regulation of Oct3/4 in ES cells causes
differentiation to endoderm/mesoderm or to troph ectoderm,
respectively, indicating that a narrow range of the amount of Oct3/
4 is critical for maintaining pluripotency (Niwa et al., 2000).
Relatively small shifts in Oct3/4 expression thus lead to commitment
of stem cells to different cell lineages. As Oct3/4 is speciﬁcally
expressed in germline cells, this molecule may be crucial throughout
the development of germline cells (Pesce et al., 1998; Pesce and
Scholer, 2000) and has actually been reported to be necessary for
survival of migrating PGCs in later stage embryos (Kehler et al., 2004).medical Research, Institute of
-1 Seiryo-machi, Sendai 980-
i).
l rights reserved.However, clariﬁcation of the speciﬁc functions of Oct3/4 in germ cell
speciﬁcation has remained elusive.
In mouse embryos, primordial germ cells (PGCs) are speciﬁed from
a population of pluripotent epiblast cells which are also the origin of
all somatic cells after implantation (Ying et al., 2001; McLaren, 2003;
Matsui and Okamura, 2005; McLaren and Lawson, 2005; Hayashi et
al., 2007). The precursors of PGCs also give rise to extra-embryonic
mesoderm including the allantoic mesoderm, and exist at the
proximal rim of the epiblast in pre-gastrulating embryos (Lawson
and Hage,1994). Those cells may be induced and/or maintained by the
function of BMP signaling from the adjacent extra-embryonic
ectoderm (Lawson et al., 1999; Ying et al., 2000; Yoshimizu et al.,
2001; Chang and Matzuk, 2001; Ying et al., 2001; Tremblay et al.,
2001; Hayashi et al., 2002; Chu et al., 2004; Chuva de Sousa Lopes et
al., 2004; Okamura et al., 2005). Blimp1, known as a transcriptional
repressor, is initially detected in lineage-restricted PGC precursors
in proximal epiblast and functions as a critical determinant of the
germ cell lineage by transcriptional repression of homeobox genes
essential for somatic cell differentiation (Vincent et al., 2005;
Ohinata et al., 2005). Before ﬁnally differentiating to PGCs, the
precursors cluster and interact with each other in extra-embryonic
mesoderm, and this interaction causes the expression of PGC-speciﬁc
genes such as Stella/PGC7 and tissue non-speciﬁc alkaline phos-
phatase (TNAP) (Sato et al., 2002; Saitou et al., 2002; Okamura
et al., 2003). In this study, we examined the function of Oct3/4 in
PGC speciﬁcation by generation of chimeric embryos with ES cells
577D. Okamura et al. / Developmental Biology 317 (2008) 576–584showing distinct levels of Oct3/4 expression, and found that Oct3/4
plays an essential role when the clustered PGC precursors are ﬁnally
speciﬁed into PGCs.
Material and methods
ES cell culture and generation of chimera embryos
G3-3 ES cells were generated by transfecting a pCAG-EGFP-IP construct into ZHBTc4
ES cells (Niwa et al., 2000, 2002). G4-2 ES cells were obtained by transfecting a pCAG-
EGFP-IP construct into ES cells containing one allele of pou5f1. GOWT1 and 4EOGR1 ES
cells were generated by introducing the pCAG-EGFP-Oct3/4-IP and pCAG-EGFP-Oct3/4-
GR-IP fusion constructions, respectively, into ZHBTc4 ES cells. EGFP-Oct3/4-GR was
generated by in-frame fusion of EGFP-Oct3/4 and the ligand binding domain of human
glucocorticoid receptor. These ES cells were maintained as described previously (Niwa
et al., 2000). For generating chimeric embryos, 10 cells of each ES cell line were injected
into C57BL/6 blastocysts, which were then transplanted into the uteri of pseudopreg-
nant ICR females.
Animal care and experiments were approved by the Institutional Ethical Committee
of the Institute of Development, Aging and Cancer, Tohoku University, and the Research
Institute of Osaka Medical Center for Maternal and Child Health.
Immunological staining
Immunostaining of whole embryos and cultured explants was performed as
previously described (Ciruna and Rossant, 2001). Primary antibodies were used at a
1:300 dilution for rabbit anti-Oct3/4 (Shimazaki et al., 1993), at a 1:10000 dilution for
rabbit anti-PGC7 (Sato et al., 2002), and at 1:1000 dilutions for rabbit anti-mil-2 and
mouse anti-Integrin α7 (6A11) (MBL). For rabbit anti-phospho-Smad1/5/8 (Cell
Signaling TECHNOLOGY, #9511), whole-mount immunostaining was performed at a
1:25 dilution of primary antibody as described (Chuva de Sousa Lopes et al., 2003).
Dissection of embryos and explant culture
Dissection of embryos and the explant culture of extra-embryonic mesoderm of
chimeric embryos were performed as described (Okamura et al., 2003). Staging of
embryos has been described previously (Downs and Davies, 1993). Explants of extra-
embryonic mesoderm were cultured for 36 h before processing for immunological
staining with Stella/PGC7 antibody. Doxycycline and Dex amethasone were added at a
concentration of 1 μg/ml and 100 nM, respectively.
Single cell analysis
GFP-positive or -negative single cells were picked up using a micro-manipulator
from dissociated proximal epiblast at pre-streak stage (E6.25) and extra-embryonic
mesoderm at the late streak (E7.0) of G3-3 chimeric embryos. cDNA was synthesized
from each single cell and then subjected to PCR ampliﬁcation. As described previously
(Dulac, 1998; Saitou et al., 2002), the ampliﬁed cDNAs were separated by agarose gel
electrophoresis, and the gels were then stained with ethidium bromide and blotted
onto nylon membranes. The membranes were hybridized with the Oct3/4, Fragilis/
mil-1 probes, or with the GAPDH probe as an internal control. In some cases, the
ampliﬁed cDNA was subjected to RT-PCR using the following primer pairs: (Cdx2-5)
5′-GTC TGG GCT TTC TTC TCC ACA A-3′, (Cdx2-3) 5′-CCC TTC ACC ATA CAA CTT CTC
TAC C-3′, (Integrin α7-5) 5′-GGA GTA AGT TGC TAG CAT ACG TTG-3′, (Integrin α7-3)
5′-CAG TGA CAC AGT CTC TTC CCT-3′, (Blimp1-5) 5′-CTT ACT GAC CTG TTG CTG TGA
CT-3′, (Blimp1-3) 5′-GTT CAT TGT GGG CTC AAC ACT CT-3′, (HPRT-5) 5′-GGA TTT GAA
ATT CCA GAC AAG-3′ and (HPRT-3) 5′-GCA TTT AAA AGG AAC TGT TGA C-3′. The PCR
conditions were 40 cycles of 94 °C for 30 s, 1 cycle of 55 °C for 1 min and 1 cycle of
72 °C for 1 min.
Results
To examine the possible roles of Oct3/4 in PGC speciﬁcation, we
attempted to observe the behavior of the PGC precursors, derived
from ES cell lines in which the Oct3/4 gene had been genetically
manipulated, in chimeric embryos. We ﬁrst used the ES cell line G3-3,
a GFP-marked derivative of ZHBTc4 ES cells lacking both alleles of the
endogenous Oct3/4 gene (Niwa et al., 2000). Their pluripotency was
maintained by an exogenously introduced Oct3/4 transgene, the ex-
pression of which could be suppressed by tetracycline or its derivative,
doxycycline (Dox) via the Tet-Off system (Niwa et al., 2000). We
planed to examine the possible effect of Dox on exogenous Oct3/4
expression and PGC formation in the chimeric embryos at early- to
mid-streak stages and in explant culture of the chimeric extra-
embryonic mesoderm inwhich PGC precursors differentiate into PGCs
(Okamura et al., 2003).The expression of Oct3/4 protein in G3-3 ES-derived cells and their
behavior in chimeric embryo
We ﬁrst examined the behavior of the ES-derived cells in pre-
and early- implantation embryos. Before implantation, the G3-3
ES-derived GFP-expressing cells intermingled with the recipient
inner cell mass, both of which showed comparable Oct3/4 pro-
tein expression in blastocyst (Figs. 1A–D). However, we unexpect-
edly found that exogenous Oct3/4 protein expression in the ES-
derived cells was gradually repressed in most of the G3-3 derived
cells after implantation without Dox (Figs. 1E–P), and this re-
pression occurred at the transcriptional level (Fig. 1Q). The same
results were obtained using another cell line independently derived
from ZHBTc4 cells (data not shown). Although the precise mecha-
nism of this repression is currently unknown, it is likely that
transcription of the exogenous Oct3/4 transgene in the ZHBTc4-
derived cells was constitutively suppressed after differentiation into
epiblast cells due to a possible position effect of the integration site
of the transgene. In addition, most of the G3-3-derived cells that
lost Oct3/4 expression were preferentially localized at the proximal
region of the epiblast after implantation (Figs. 1E–P and Figs.
2D–O).
G3-3 ES-derived cells lacking Oct3/4 expression exhibited the properties
of proximal epiblast cells
As repression of Oct3/4 in ES cells induces loss of pluripotency and
differentiation to trophectoderm (Niwa et al., 2000), the G3-3-derived
cells most likely differentiated to trophectoderm-derived extra-
embryonic ectoderm, and might have been sorted toward extra-
embryonic ectoderm in chimeric embryos. To test this possibility,
expression of molecules speciﬁcally expressed either in proximal
epiblast or extra-embryonic ectoderm was examined by immunos-
taining (Figs. 2A–O). The results indicated that the G3-3-derived cells
showed the signals of activated Smad1/5/8 whose activation is
normally induced in proximal epiblast cells by the BMPs signals
from the extra-embryonic ectoderm (Figs. 2A–G) (Hayashi et al., 2002;
Chuva de Sousa Lopes et al., 2004). They also expressed mil-2 (Figs.
2H–K) (Tanaka and Matsui, 2002), speciﬁcally expressed in PGC
precursors and PGCs (data not shown). On the other hand, the
expression of Integrin-α7 (Klaffky et al., 2001) and Cdx2 (Beck et al.,
1995), speciﬁc markers of extra-embryonic ectoderm, was undetect-
able in G3-3-derived GFP-expressing cells by immunostaining (Figs.
2L–O) and by RT-PCR (Fig. 2P), indicating that these cells were not
extra-embryonic ectoderm cells. Taken together, these results indicate
that the G3-3-derived cells lacking Oct3/4 expression and preferen-
tially localizing at the proximal region of the epiblast had the
properties of proximal epiblast cells, including PGC precursors, but
not of extra-embryonic ectoderm.
It is possible that even a small amount of Oct3/4 protein below the
sensitivity of our immunostaining procedure may still be active in
epiblast cells. To examine this possibility, we cultured G3-3 ES cells in
the presence of Dox at different concentration, and found a nice
correlation between the level of detectable Oct3/4 protein and its
functional activity (Fig. S1).
G3-3 ES-derived cells lacking Oct3/4 expression contributed to PGC
precursor-like cells, but failed to form PGCs
As indicated above, the G3-3-derived cells without detectable
Oct3/4 expression were able to contribute to proximal epiblast, and
some expressed a marker of PGC precursors (Fig. 2). We further
observed the developmental fates of the G3-3-derived cells in early
gastrulating chimeric embryos. Most of G3-3-derived cells moved
into extra-embryonic mesoderm, and some of them at the tip of the
extra-embryonic mesoderm formed a cluster of cells together with
Fig. 1. The Oct3/4 expression in G3-3-derived cells was transcriptionally repressed after implantation, which was accompanied by localization of these cells at the proximal region
of the epiblast in chimeric embryos. (A–D) After culturing for 18 h, G3-3 ES cells (yellow arrowheads) injected into E3.5 blastocyst were intermingled with the recipient inner cell
mass (white arrowheads), and both of these cells showed comparable Oct3/4 protein expression. (E–H) After implantation, G3-3-derived GFP-expressing cells (yellow
arrowheads) showed weaker expression of Oct3/4 protein than recipient epiblast cells at E5.0, and its expression was undetectable in some cells (white arrowhead). (I–L) At E5.5,
the ES-derived cells (yellow arrowheads) lost Oct3/4 protein and localized at the proximal region of the epiblast. (M–P) The ES-derived cells were still preferentially localized at
the most proximal region of the epiblast at the pre-gastrulation stages, E6.25. Among these cells, a small number of the G3-3-derived cells incidentally escaped the repression of
Oct3/4 expression (* in panels M–P). TOTO-3 staining of nuclei (C, G, K, O) and merged images (D, H, L, P). Scale bar, 50 μm (A–P). (Q) Single-cell cDNA analysis by cDNA southern
hybridization revealed that Oct3/4 transcript was undetectable or at quite low levels in G3-3-derived cells at the proximal region of the epiblast in chimeric embryos, while its
expression was evident in the surrounding GFP-negative recipient epiblast cells.
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heads). The clustered ES-derived cells also expressed Fragilis/mil-1
(Fig. 3M) (Saitou et al., 2002, Tanaka and Matsui, 2002) and Blimp1
(Fig. 3N) (Ohinata et al., 2005) at high frequency, indicating that they
were PGC precursors-like cells, even though Oct3/4 protein was still
down-regulated in these cells (Fig. 3M). We next examined whether
the clustered G3-3-derived PGC precursors-like cells could be
speciﬁed to PGCs at a subsequent stage. We stained the chimeric
embryos at E7.25–7.5 with an antibody to Stella/PGC7 to identifynascent PGCs (Sato et al., 2002; Saitou et al., 2002). Despite the
efﬁcient contribution to PGC precursor-like cells, most of the ES-
derived cells did not express Stella/PGC7 (Figs. 3I–L, blank arrow-
heads), and the expression of Oct3/4 protein was still suppressed
(Figs. 3E–H, blank arrowheads). In contrast, the recipient embryo-
derived cells expressed Stella/PGC7 (Figs. 3I–L). Taken together, these
results suggest that the G3-3-derived cells formed PGC precursors-
like cells without detectable Oct3/4 expression, but failed to diffe-
rentiate into PGCs.
Fig. 2. The G3-3 ES-derived cells exhibited the properties of proximal epiblast cells, but not of extra-embryonic ectoderm. (A–C) In normal embryos, the expression of phosphorylated
and activated Smad proteins at the proximal region of the epiblast was much higher than that at the distal region at E6.25, but its signal was not detected in extra-embryonic
ectoderm. (D–O) In the chimeric embryo, the G3-3 ES-derived cells in the proximal region of the epiblast showed signals for phosphorylated Smad proteins (D–G, yellow arrowheads)
and mil-2 proteins (H–K), but they did not express Integrin-α7, a marker of extra-embryonic ectoderm (L–O). White blank arrowheads indicate the border between epiblast and
extra-embryonic ectoderm (A–O). TOTO-3 staining of nuclei (B, F, J, N) andmerged images (C, G, K, O). Scale bar, 50 μm (A–G) and 25 μm (H–O). (P) Single-cell cDNA analysis by RT-PCR
revealed that transcripts for extra-embryonic ectodermmarkers, Cdx2 and Integrin-α7, were undetectable in proximal epiblast cells including the GFP-positive G3-3 ES-derived cells
and the GFP-negative recipient cells.
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speciﬁcation to PGCs
To clarify the impact of loss of Oct3/4 expression in PGC
speciﬁcation, we next attempted to rescue the Oct3/4 expression in
chimeric embryos using GOWT1 ES cells, which are also a derivative of
the ZHBTc4 cells but have an additional Oct3/4-GFP fusion transgene
under the control of the CAG promoter. The GOWT1 ES-derived cells
were uniformly distributed within the epiblast (data not shown) and
extra-embryonic mesoderm (Figs. 4A, E). In addition, most of the GFP-
expressing GOWT1-derived cells showed comparable expression ofOct3/4 protein to that in surrounding recipient cells (Figs. 4A–D), and a
portion of GOWT1-derived cells within the extra-embryonic meso-
derm successfully expressed Stella/PGC7 (Figs. 4E–H). These results
suggest that the rescued Oct3/4 expression in the ES-derived cells
restored the ability of speciﬁcation to PGCs.
Suppression of Oct3/4 expression caused failure of PGC speciﬁcation in
cultured extra-embryonic mesoderm
To further determine the requirement of Oct3/4 protein for PGC
speciﬁcation, fragments of extra-embryonic mesoderm containing
Fig. 3. The G3-3 ES-derived cells continuously repressed for Oct3/4 expression were able to contribute to PGC precursor-like cells, but failed to form PGCs. (A–D) A cluster of PGC
precursors expressing mil-2, a speciﬁc marker of PGC precursors, was composed of G3-3 ES-derived GFP-expressing cells and GFP negative recipient cells in extra-embryonic
mesoderm at E7.0 (arrowheads). (E–L) At E7.25, clustered GFP-expressing G3-3-derived cells, in which Oct3/4 protein was constitutively down-regulated (E-H, blank arrowheads),
failed to be PGC7/Stella-positive PGCs (I–L, blank arrowheads). TOTO-3 staining of nuclei (C, G, K) and merged images (D, H, L). Scale bar, 50 μm. (M, N) Ampliﬁed single-cell cDNA
obtained from extra-embryonic mesoderm in the G3-3-chimeric embryos at E7.0 were subjected to Southern blot analysis (M) and RT-PCR (N). Most of the clustered G3-3-derived
GFP-expressing cells showed transcriptional suppression of Oct3/4 (M), and expression of Fragilis/mil-1 (M) and Blimp1 (N), speciﬁc markers of PGC precursors.
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(Okamura et al., 2003) (Fig. 5). The extent of the contribution of ES
cells to extra-embryonic mesoderm varies among chimeric embryos,
which may affect the efﬁciency of PGC speciﬁcation from the ES-
derived cells. Thus for culture we selected chimeric embryos showing
over 50% chimerism in extra-embryonic mesoderm, which was
estimated by the area of GFP expression. After culture, the explants
were stained with the antibody for Stella/PGC7 and the number of
Stella/PGC7-positive PGCs was counted. In cases where the explants
from the chimeric embryos of the ES cells were heterozygous for theendogenous Oct3/4 alleles (G4-2) and of GOWT1 cells, over 60% of
Stella/PGC7-positive cells co-expressed GFP (Figs. 5A–H and M, Table
1), while only 12.6% of Stella/PGC7-expressing cells were GFP positive
in explants from the G3-3 chimeric embryos (Figs. 5I–M, Table 1).
Most of the recipient-derived Stella/PGC7-expressing PGCs and
Stella/PGC7-negative G3-3-derived cells were located within the
same cluster of cells (Figs. 5I–L), further supporting the idea that G3-
3-derived cells preferentially contribute to a cluster of PGC
precursors, but fail to be speciﬁed into PGCs. Although the expression
of the Oct3/4 protein was mostly suppressed in the G3-3-derived
Fig. 4. Rescued Oct3/4 expression in the ES-derived cells restored the ability of speciﬁcation to PGCs. (A–D) GOWT1-derived GFP-expressing cells, in which expression of Oct3/4 was
rescued by an additional Oct3/4 transgene, showed Oct3/4 protein expression at a comparable level to that of surrounding GFP-negative recipient cells in the extra-embryonic
mesoderm at E7.25 (arrowheads). (E–H) PGC7/Stella-positive PGCs emerged from GOWT1-derived cells (arrowheads). TOTO-3 staining of nuclei (C, G) and merged images (D, H).
Scale bar, 50 μm (A–H).
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may explain why a few PGCs derived from G3-3 ES cells were found
(Fig. 5M, Table 1). To examine this possibility, the explants of G3-3
chimeric embryos were cultured in the presence of doxycycline (Dox)
to completely suppress the Oct3/4 expression in the ES-derived cells.
As expected, Dox markedly reduced the number of G3-3-derived
PGCs in the explants, while it had no effect on PGC emergence from
recipient cells (Fig. 5M, Table 1 and data not shown). As we
previously reported, cells showing Stella/PGC7 expression in the
cultured explants were also positive for TNAP (tissue non-speciﬁcFig. 5. Suppression of Oct3/4 expression caused failure of PGC speciﬁcation in cultured ex
chimeric embryos containing PGC precursors were cultured on a feeder layer of STO cells. Aft
embryos of G4-2 ES cells, which were heterozygous for the endogenous Oct3/4 alleles (A–D)
(arrowheads, * shows recipient-derived PGCs). (I–L) In explants from G3-3 chimeric embryos
extra-embryonic mesodermwere stained using anti-Stella/PGC7 (B, F, J). TOTO-3 staining of n
emergence from the ES-derived cells in cultured explants of extra-embryonic mesoderm. Th
plotted with a red circle, and medians are depicted by a black stripe. Doxycycline (Dox) waalkaline phosphatase) activity or its gene expression, which is the
alternative speciﬁc marker of PGCs (Okamura et al., 2003, 2005;
Chuva de Sousa Lopes et al., 2004), which was also conﬁrmed in this
study (data not shown).
Conditional Oct3/4 expression in ES-derived PGC precursors affected PGC
speciﬁcation
We further conﬁrmed the requirement of Oct3/4 for PGC spe-
ciﬁcation using another ZHBTc4-derived ES cell line, 4EOGR1, inwhichtra-embryonic mesoderm. (A–L) Fragments of extra-embryonic mesoderm from E6.75
er culture, explants were stained with anti-PGC7/Stella. (A–H) In explants from chimeric
, and of GOWT1 ES cells (E–H), most of the Stella/PGC7-positive cells co-expressed GFP
, few Stella/PGC7-expressing cells were GFP positive (arrowheads). Cultured explants of
uclei (C, G, K) and merged images (D, H, L). Scale bar, 50 μm (A–L). (M) Efﬁciency of PGC
e ratio of the ES-derived cells in all of the PGC7/Stella-positive cells in each explant was
s added to the culture medium at the indicated concentration.
Table 1
The restoration of Oct3/4 protein and its activity in PGC precursors is necessary for PGC
speciﬁcation
Type of
explants
Doxycycline
(1 μg/ml)
Dexamethasone
(100 nM)
ES-derived cells/
Stella/PGC7-
positive cells
(%)a
G4-2 − − 123/199 61.8±22.6 n=7
(explants)
GOWT1 − − 90/122 73.8±22 n=11
G3-3 − − 27/213 12.6±8.7 n=8
G3-3 + − 1/137 0.7±1 n=6
4EOGR1 + − 4/48 8.8±9 n=4
4EOGR1 + + 43/60 71.6±15.6 n=4
a Include standard deviations (±).
582 D. Okamura et al. / Developmental Biology 317 (2008) 576–584a dexamethasone (Dex)-dependent GFP-Oct3/4-GR fusion trans-
gene was introduced into ZHBTc4 cells. In culture of 4EOGR1 ES
cells, addition of doxycycline (Dox) completely suppressed Oct3/4Fig. 6. Conditional Oct3/4 expression in 4EOGR1 ES-derived PGC precursors affected PGC spe
response to dexamethasone (Dex). One hour after addition of Dex (100 μM), most signals of t
h later, all signals had translocated to the nucleus (C, D). (E–L) Fragments of extra-embryo
presence of doxycycline (Dox) (E–H), or of both Dox and Dex (I–L). Cultured explants were
positive cells were derived from the GFP-negative recipient cells (arrowheads). (I–L) In the
contributed to PGC7/Stella-positive cells (arrowheads). Cultured explants of extra-embryon
andmerged images (H, L). Scale bar, 25 μm (A–D) and 50 μm (E–L). (M) Efﬁciency of PGC emer
The ratio of the ES-derived cells in all of the PGC7/Stella-positive cells in each explant was p
added to the culture medium at the indicated concentration.activity and resulted in differentiation of the cells, as in the parent
ZHBTc4 cells, while addition of Dex maintained their pluripotency
even in the presence of Dox (Fig. S2). By administration of Dex, the
GFP-Oct3/4-GR fusion protein in 4EOGR1 ES cells changes their
conformation and translocated from cytoplasm into nucleus within
3 h (Figs. 6A–D and data not shown). Using the ES cells, we
expected that the Oct3/4 activity in the chimeric embryos could be
conditionally manipulated by Dex. Fragments of extra-embryonic
mesoderm of the 4EOGR1-chimeric embryos at E6.75 were
cultured with Dox, or Dox and Dex. In the presence of Dox only,
most of the ES-derived GFP-positive cells failed to express PGC7/
Stella, as was the case for G3-3 cells (Figs. 6E–H and M, Table 1),
while in the presence of both Dox and Dex, the ES-derived cells
were able to contribute to PGC7/Stella-positive cells (Figs. 6I–L and
M, Table 1). Localization of the GFP-Oct3/4-GR fusion protein
detected by GFP ﬂuorescence indicated Dex-dependent transloca-
tion of the fusion protein into the nucleus (Figs. 6A–D and I–L),
conﬁrming the conditional activation of the Oct3/4 function in the
explants. On the whole, these results indicate that activity of Oct3/ciﬁcation. (A–D) The GFP-Oct3/4-GR fusion proteins in 4EOGR1 ES cells showed a quick
he GFP-Oct3/4-GR fusion proteinwere still dispersed in the cytoplasm (A, B). However, 6
nic mesoderm from E6.75 chimeric embryos of 4EOGR1 ES cells were cultured in the
stained with anti-PGC7/Stella. (E–H) In the presence of Dox, most of the PGC7/Stella-
presence of Dex as well as Dox, the GFP-expressing 4EOGR1 ES-derived cells efﬁciently
ic mesoderm were stained using anti-Stella/PGC7 (F, J). TOTO-3 staining of nuclei (G, K)
gence from 4EOGR1 ES-derived cells in cultured explants of extra-embryonicmesoderm.
lotted with a red circle, and medians are depicted by a black stripe. Dox and Dex were
Fig. 7. Oct3/4 plays critical roles in PGC speciﬁcation. Oct3/4 expression in the clustered PGC precursors is essential for the ﬁnal speciﬁcation of PGCs. Oct3/4 may regulate expression
of genes conferring the properties of the nascent PGCs on the PGC precursors. After the PGC speciﬁcation, expression of Oct3/4 protein is maintained only in PGC7/Stella-expressing
nascent PGCs, while in surrounding somatic cells, it is rapidly down-regulated and ﬁnally disappears.
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speciﬁed to PGC.
Discussion
A recent study concerning functions of the transcriptional re-
pressor Blimp1 in PGC development revealed that this molecule in the
PGC precursors may repress the expression of genes involved in
somatic cell differentiation and induce the precursors to PGCs
(Vincent et al., 2005; Ohinata et al., 2005). However, independent
transcriptional regulation, including induction of genes required for
maintenance and further speciﬁcation to PGCs, in their precursors
may also play essential roles. In the present study, we revealed that
Oct3/4 activity is essential for PGC speciﬁcation, but is dispensable for
formation and maintenance of their precursors.
We initially designed experiments in which Oct3/4 transcription
was repressed in the presence of Dox using G3-3 ES cells, but we
subsequently found that the expression of Oct3/4 in the ES-derived
cells was gradually repressed in the chimeric embryos after
implantation in a Dox-independent manner, probably due to integra-
tion site-dependent repression of the Oct3/4 transgene after differ-
entiation of ES cells (Figs. 1 and 3). On the other hand, the additional
transgene in GOWT1 ES cells is likely to be integrated in a different
location in the genome, and therefore does not suffer the site-
dependent repression (Fig. 4).
Even in the absence of Oct3/4 expression after implantation, we
found that the G3-3-derived cells successfully contributed to proximal
epiblast cells and PGC precursor-like cells in the chimeric embryos
(Figs. 1–3). None of these cells expressed the markers of extra-
embryonic ectoderm, and some expressed activated Smads and mil-2
protein, which are normally expressed in proximal epiblast as well as
in PGC precursors (Fig. 2). Because Oct3/4 is expressed in all epiblast
cells including the precursors of PGCs, the signiﬁcance of precursor
formation independent of Oct3/4 is currently unclear. However, a
recent report indicated that the expression of Sox2, a heterodimeric
partner of Oct3/4, is up-regulated at the time of PGC speciﬁcation
(Yabuta et al., 2006), suggesting that Oct3/4 becomes functional in the
PGC precursors after expression of cooperative factors such as Sox2.
The present study also revealed that the Oct3/4 function is
essential for the precursors to be speciﬁed to PGCs. We initially used
two different ES cell lines, G3-3 and GOWT1, both of which were
derived from ZHBTc4 ES cells (Niwa et al., 2000). These ES-derived
cells showed differential expression of Oct3/4 in chimeric embryos,
which most likely affected the efﬁciency of PGC formation from ES-derived cells (Figs. 3–5, Table 1). However, it is also possible that these
ES cell lines may have additional differences generated during
establishment from ZHBTc4, which might affect their ability to form
PGCs. To exclude this possibility, we used another ZHBTc4-derived ES
cell line, 4EOGR1, in which the Oct3/4 function could be conditionally
induced by Dex, and the results further indicated that the Oct3/4
activity was critical for PGC speciﬁcation (Fig. 6, Table 1).
We previously found that interaction among the PGC precursors
mediated by a cell adhesion molecule, E-cadherin, plays a role in the
ﬁnal step of PGC speciﬁcation (Okamura et al., 2003). E-cadherin may
directly or indirectly transmit essential intracellular signals into the
PGC precursors, which may activate transcription of essential genes
required for ﬁnal events of PGC speciﬁcation, and Oct3/4 may colla-
borate with the putative E-cadherin-dependent signaling (Matsui
andOkamura, 2005). A previous studyalso indicated the importance of
Blimp1 in the PGC precursors, and this transcription factor affects
genes required for somatic cell differentiation (Vincent et al., 2005;
Ohinata et al., 2005). In addition to the functions of Blimp1, it is most
likely that distinct transcriptional cascades activate a group of genes
that are essential for the initial steps of PGC differentiation, and Oct3/4
may play a key role in this process (Fig. 7). Identiﬁcation of possible
target genes of Oct3/4 in nascent PGCs in future studies is a desirable
approach to clarify the mechanisms of PGC speciﬁcation.
Oct3/4 is necessary for survival of migrating PGCs in later stage
embryos (Kehler et al., 2004). It is also expressed in spermatogonial
stem cells as well as in growing and mature oocytes (Pesce et al.,
1998). Although its functions in these cells are unknown, it is likely
that Oct3/4 may also play important roles in the maintenance of
spermatogonial stem cells and in the establishment of pluripotency in
oocytes, and therefore investigating the possible functions of Oct3/4 in
later germ cells is an attractive subject for future studies.
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